News

Medtronic Inc. announced the first patient enrollment in the WRAP Infection Clinical Trial, which will evaluate the effectiveness of the TYRX Absorbable Antibacterial Envelope in reducing major infections in patients with cardiac implantable electronic devices (CIEDs) at risk for infection.

Home January 22, 2015
Home
News

In a rural Maine county, sustained community-wide programs targeting cardiovascular risk factors and behavior changes were associated with reductions in hospitalization and death rates over a 40-year period (1970-2010) compared with the rest of the state. Substantial improvements were seen in control of hypertension, cholesterol and smoking cessation, according to a study in the January 13 issue of the Journal of the American Medical Association (JAMA).

Home January 21, 2015
Home
rivaroxaban, Xarelto, safety performance, Janssen, NVAF
Feature

A new post-marketing study evaluating the safety of once-daily rivaroxaban (Xarelto) shows, in patients with non-valvular atrial fibrillation (NVAF), rates and patterns of major bleeding in routine clinical practice are generally consistent with those observed in Phase 3 clinical trials used to approve the medicine for this indication. These 15-month results, published in Clinical Cardiology, represent initial findings from an ongoing, five-year observational study of patients using rivaroxaban daily over the course of their lives.

Home January 21, 2015
Home
News

Sunshine Heart Inc. announced the company's German Erlangen site for the OPTIONS-HF study has implanted its first patient with the C-Pulse(R) System for moderate to severe heart failure.

Home January 21, 2015
Home
News

The number of IVC filters placed has more than doubled in the last 10 years, and by some estimates, less than half of these retrievable devices are actually removed each year.

Home January 21, 2015
Home
ACC 2015 late breaking trials
Feature

The latest data on TAVR, transcatheter mitral valve repair, the use of CT to evaluate chest pain, first report on the use of TAVR embolic protection, denervation for pulmonary arterial hypertension, and outcomes with drug-eluting stents vs. bypass surgery.

Home January 21, 2015
Home
News

There could soon be new hope for those facing one of humanity's biggest health issues, thanks to research from the University of Tennessee Knoxville College of Engineering.

Home January 20, 2015
Home
News

A study involving scientists from the University of Leicester has established a link between hypoglycaemia and increased risk of cardiovascular events and mortality in patients with diabetes.

Home January 20, 2015
Home
News

Biotronik announced the first enrollments in its prospective, multi-center, international Reduce-TE Pilot study (Reduction of AF Ablation Induced Thrombo-Embolic Incidence).

Home January 20, 2015
Home
Technology

The U.S. Food and Drug Administration (FDA) has granted a humanitarian device exemption for the CVRx Inc. Barostim neo Legacy System.

Home January 19, 2015
Home
News

Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have shown that the risk of heart disease is higher in this group of women after radiation treatment because it can be difficult to ensure that a sufficient dose of radiation is delivered to the left breast while adequately shielding the heart from exposure. New research shows a woman who holds her breath during radiation pulses can greatly reduce radiation exposure to the heart.

Home January 19, 2015
Home
News

The American Society of Nuclear Cardiology (ASNC) has announced the launch of the first cardiovascular nuclear imaging data registry, ImageGuide.

Home January 19, 2015
Home
News

Direct Flow Medical Inc. announced the closing of a new round of financing for the company totaling $32 million.

Home January 19, 2015
Home
News

Bellerophon Therapeutics LLC announced that it has completed enrollment of its PRESERVATION I clinical trial of Bioabsorbable Cardiac Matrix (BCM), an investigational implantable medical device being studied for the prevention of congestive heart failure following an acute myocardial infarction (AMI). The procedure has been completed in 303 patients at almost 90 clinical sites in Australia, Europe, Israel and North America. The company expects to report top line results in mid-2015, following a six-month follow-up period for all patients.

Home January 16, 2015
Home
News

Supplementing written heart screening guidelines with telephone counseling from specially trained nurses more than doubled the likelihood that adult survivors of childhood cancer received recommended heart checks, according to results from the Childhood Cancer Survivor Study (CCSS). St. Jude Children's Research Hospital investigators led the research, whose findings appear in the current issue of the Journal of Clinical Oncology.

Home January 16, 2015
Home
Subscribe Now